SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,118,618 | +75.6% | 9,228 | +65.9% | 0.09% | +45.8% |
| Q2 2023 | $636,960 | -43.2% | 5,562 | -31.7% | 0.06% | -78.1% |
| Q1 2023 | $1,121,936 | -31.3% | 8,140 | -35.4% | 0.27% | -33.1% |
| Q4 2022 | $1,633,485 | +1601.5% | 12,606 | +1349.0% | 0.40% | +2412.5% |
| Q3 2022 | $96,000 | +1820.0% | 870 | +1281.0% | 0.02% | +1500.0% |
| Q2 2022 | $5,000 | -68.8% | 63 | -63.8% | 0.00% | -83.3% |
| Q4 2021 | $16,000 | -15.8% | 174 | -17.1% | 0.01% | -14.3% |
| Q3 2021 | $19,000 | – | 210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |